Ready-to-Use Lentivirus for miRNA Expression and Inhibition|
Saturday, February 01, 2014
AMSBIO’s anti-miRNA lentivirus are produced from the optimally designed anti miRNA lentivectors.
Almac Announces the Presentation of External Validation of ColDx Signature
Friday, January 31, 2014
Data presented supporting Almac developed colon signature as a significant predictor of risk of recurrence in stage II colon cancer.
Massachusetts General Hospital Adopts Advanced Analytical Technology in Fight Against Cancer
Thursday, January 16, 2014
Company's Fragment Analyzer evaluates DNA and RNA of cancer patients.
Affymetrix to Host Workshop on Genomic Selection at PAG Conference
Thursday, January 09, 2014
Plant and animal genome conference at PAG XXII on Monday, January 13 in San Diego.
Compugen to Significantly Expand Immuno-Oncology Activities During 2014
Wednesday, January 08, 2014
R&D expenditures for 2014 anticipated to increase by more than 60%.
ProCure Proton Centers Select RayStation® for Proton Planning
Thursday, December 26, 2013
CE marking and clearance in the US for PBS is expected in early 2014.
Agilent Introduces Two New ScreenTape Assays
Wednesday, December 18, 2013
Two new assays to optimize next-generation sequencing quality control, performance, throughput.
Promega Introduces QuantiFluor ONE dsDNA System
Friday, December 06, 2013
QuantiFluor ONE dsDNA system expands Promega’s nucleic acid quantitation offering.
Cell Therapy Company Uses TAP’s Fill-It Automated Cryovial Processing System
Thursday, December 05, 2013
To rapidly produce consistent cancer immunotherapy batches and cell banks.